Bristol Myers' New Drugs Drive Upbeat Outlook. The Stock Is On the Mend.

Bristol Myers Squibb’s fourth-quarter earnings and revenue beat Wall Street expectations.

Related Keywords

George Frey Bloomberg ,Bristol Myers Squibb ,Myers Squibb ,Article Normal ,Pharmaceuticals ,Wholesalers ,Retail Wholesale ,Healthcare Life Sciences ,Synd ,Earnings Report ,Biotech And Pharma ,Markets ,North America ,Healthcare ,Rapid Response ,Johnson Amp ,Jnj ,Astrazeneca ,Azn Ln ,Uk Azn ,Bmy ,Pfizer ,Pfe ,Retail ,Wholesale ,Life Sciences ,